Viking Therapeutics, Inc.

Report date
3/31/2026
Quarter
2026 Q1
Filed
4/13/2026
Shares
60,573
Value ($000)
1,971
Weight
0.0%
2019 Q4 - 2026 Q1 (19 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).